Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02007213 · ClinicalTrials.gov registry record

Development of a Proxy Motor Outcome Measure in Young Children With Neuromuscular Disease

A clinical trial, sponsored by National Institute of Nursing Research (NINR).

Terminated
Registry status
49
Enrollment target

NCT02007213 is a clinical trial that was terminated before completion, run by National Institute of Nursing Research (NINR). The registered enrollment target is 49 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02007213 was terminated before completion, sponsored by National Institute of Nursing Research (NINR).

TERMINATED
Registry status
49 participants
Enrollment target

Study Summary

Patient reported outcomes (PROs) instruments are often used to measure meaningful treatment benefit or risk in clinical trials. PROs allow patients voices to be heard in ways that assist healthcare clinicians to address treatment effects and individual patient preferences. Unfortunately, infants and young children, especially those with a debilitating disease, such as neuromuscular disorders (NMD), may be less able to provide clear and concise information about treatment effects. In this case, we often defer to parents and guardians (to be referred to collectively as parents throughout protocol) to provide their perception of their child s overall health and wellbeing. Including parents in the assessment process recognizes the unique knowledge parents have of their child s development, reinforces their central role in implementing interventions, and aids in their ability to make better-informed healthcare decisions \[1\]. Yet, most parent-reports for young children are confined to overall quality of life (QoL). While QoL is an important area of assessment, its meaning varies among different ages and populations, and its results are often not precise enough to reveal small differences within samples \[2\]. A more specific area of concern in children with NMD is early-onset muscle weakness leading to difficulties in motor function. The current lack of patient-centered, sensitive measures (based on motor function and item difficulty hierarchy) that are suited for repeated assessments in infants and young children with NMD represents a major obstacle to the rapid translation of promising therapeutic interventions from preclinical models to clinical research studies. Multiple clinical outcome measures used at a single time-point for capturing a child s functional status are burdensome, difficult to interpret and do not provide us with comprehensive, meaningful information to detect changes following an intervention \[3\]. Psychometric measures that can be completed by p

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2013-12-05
Est. Completion 2018-03-31

What the Registry Record Tells You About NCT02007213

The ClinicalTrials.gov registry entry for NCT02007213 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Nursing Research (NINR), which has 46 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02007213 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02007213 about?

NCT02007213 is a clinical study titled "Development of a Proxy Motor Outcome Measure in Young Children With Neuromuscular Disease". Patient reported outcomes (PROs) instruments are often used to measure meaningful treatment benefit or risk in clinical trials. PROs allow patients voices to be heard in ways that assist healthcare clinicians to address treatment effects and individual patient preferences. Unfortunately, infants and...

What is the current status of trial NCT02007213?

This trial is currently terminated. The enrollment target is 49 participants. The study started on 2013-12-05. Estimated completion is 2018-03-31.

Who is sponsoring clinical trial NCT02007213?

This trial is sponsored by National Institute of Nursing Research (NINR), which has 46 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.